Edwards Lifesciences has lifted its 2025 profit outlook to between 9%-10%, up from 8%-10%, amid strong Q2 2025 performance in its Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral ...

MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s CRC screening test, ColoSense.

The Advanced Medical Technology Association (AdvaMed) has expressed support for the Trump administration’s artificial intelligence (AI) action plan.

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Brain implant company Neuralink aims to generate $1bn by 2031 following the implantation of its brain-computer interface (BCI) chips in 20,000 people.

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.

Nestmedic has chosen Curavit Clinical Research to spearhead the US clinical study of the remote prenatal monitoring solution, PregnaOne.

On 20 January 2025, the Trump administration called for a suspension of foreign aid, including global health initiatives such as the US President's Emergency Plan for AIDS Relief (PEPFAR).

The European Commission (EC) has approved a €403m ($473.3m) public funding package to support medical device innovation in the bloc.